Slovenja - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

splendris pharmaceuticals gmbh - klopidogrel - filmsko obložena tableta - klopidogrel 75 mg / 1 tableta - klopidogrel

Slovenja - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

splendris pharmaceuticals gmbh - klopidogrel - filmsko obložena tableta - klopidogrel 75 mg / 1 tableta - klopidogrel

Slovenja - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

splendris pharmaceuticals gmbh - klopidogrel - filmsko obložena tableta - klopidogrel 75 mg / 1 tableta - klopidogrel

Unjoni Ewropea - Sloven - EMA (European Medicines Agency)

extrovis eu ltd. - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Slovenja - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

generics (uk) ltd. - klopidogrel - filmsko obložena tableta - klopidogrel 75 mg / 1 tableta - klopidogrel

Unjoni Ewropea - Sloven - EMA (European Medicines Agency)

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

Unjoni Ewropea - Sloven - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - prašiči - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

Unjoni Ewropea - Sloven - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - hepatitis a virus (inactivated), hepatitis b surface antigen - hepatitis b; hepatitis a; immunization - cepiva - zdravilo ambirix se uporablja za osebe, ki niso imune, od enega leta do vključno 15 let, za zaščito pred okužbo s hepatitisom a in hepatitisom b. zaščita proti hepatitis-b, okužbe, morda ne bo mogoče uporabiti, dokler se po drugem odmerku. zato:ambirix je treba uporabiti le, ko je relativno nizko tveganje za hepatitis-b okužbo v času cepljenja seveda;priporočljivo je, da ambirix je treba dajati v okolju, kjer je zaključek dveh odmerek cepljenja seveda lahko prepričani,.

Unjoni Ewropea - Sloven - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - hepatitis a virus (inactivated), hepatitis b surface antigen - immunization; hepatitis b; hepatitis a - cepiva - twinrix pediatric je indiciran za uporabo pri neimunskih dojenčkih, otrocih in mladostnikih od enega leta do vključno 15 let, pri katerih obstaja tveganje za okužbo s hepatitisom a in hepatitisom b.

Slovenja - Sloven - Ecolab

ecolab deutschland gmbh -